Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01419080 · ClinicalTrials.gov registry record

Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)

A clinical trial, sponsored by Saint Luke's Health System.

Completed
Registry status
797
Enrollment target

NCT01419080 is a clinical trial that has completed, run by Saint Luke's Health System. The registered enrollment target is 797 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01419080 has completed, sponsored by Saint Luke's Health System.

COMPLETED
Registry status
797 participants
Enrollment target

Study Summary

An estimated 8 million individuals in America are affected by peripheral arterial disease (PAD), blockages of the leg arteries that can cause excruciating calf pain when walking. PAD can have a tremendous impact on patients' quality of life. It is also associated with high rates of heart attacks and premature death. While there are a number of treatments, there have been few previous studies that have prospectively examined treatment patterns for PAD or sought to systematically identify opportunities to improve care. Most importantly, there have been no rigorous studies examining the impact of the disease from patients' perspectives - their symptoms, function and quality of life - as a function of different patient characteristics and treatments. The PORTRAIT study (Phase II) will systematically document the treatments and health status (symptom, function and quality of life) outcomes of 840 US patients over the course of one year (assessments at baseline, 3, 6, and 12 months) from 10 centers to address these gaps in knowledge. It will illuminate whether disparities in treatment or health status outcomes exist as a function of patients' age, gender, race, socioeconomic or psychological characteristics. PORTRAIT will substantially elevate the field and identify critical gaps in the way PAD is currently managed, including potential disparities in care, so that the quality of care can be improved.

Trial Details

FieldValue
Enrollment Target 797 participants
Start Date 2013-10
Est. Completion 2016-12

Sponsor

Saint Luke's Health System

26 total trials

What the Registry Record Tells You About NCT01419080

The ClinicalTrials.gov registry entry for NCT01419080 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 797 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01419080 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01419080 about?

NCT01419080 is a clinical study titled "Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)". An estimated 8 million individuals in America are affected by peripheral arterial disease (PAD), blockages of the leg arteries that can cause excruciating calf pain when walking. PAD can have a tremendous impact on patients' quality of life. It is also associated with high rates of heart attacks and...

What is the current status of trial NCT01419080?

This trial is currently completed. The enrollment target is 797 participants. The study started on 2013-10. Estimated completion is 2016-12.

Who is sponsoring clinical trial NCT01419080?

This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.